insights_auto
Why is INO down 2,10%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,40 USD
arrow_downward
-2,10%(-0,030) 1D
1,39 USD
arrow_downward
-0,71% (-0,0100)bedtimeAfter hours
Closed: 16-ноя., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,42 USD
High
1,48 USD
Low
1,37 USD
Mkt. cap
262,23 млн
Avg. vol.
19,34 млн
Volume
6,53 млн
52-wk high
2,72 USD
52-wk low
0,57 USD
EPS
-0,80 USD
Beta
1,71
Shares outstanding
187,31 млн
No. of employees
112
Open
1,42 USD
High
1,48 USD
Low
1,37 USD
Mkt. cap
262,23 млн
Avg. vol.
19,34 млн
Volume
6,53 млн
52-wk high
2,72 USD
52-wk low
0,57 USD
EPS
-0,80 USD
Beta
1,71
Shares outstanding
187,31 млн
No. of employees
112
News stories
From web sources and news partners
Yahoo Finance
·
20 мүнөт мурун
What's dragging down the S&P 500? Apple in focus
Investing.com
·
32 мүнөт мурун
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.41%
24/7 Wall St.
·
59 мүнөт мурун
S&P 500 Closes Down 2% as Nasdaq Leads Broad Market Lower
ChartMill
·
2 саат мурун
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc